Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Vitalhub Corp. (VHI.TO)
CAD7.28
-0.02 (-0.21%)
CA TSX Healthcare Medical - Healthcare Information Services
Address
480 University Avenue M5G 1V2
Toronto, ON, CA
Toronto, ON, CA
CEO
Daniel Paul Matlow
Website
vitalhub.com
IPO
2021-09-23
ISIN CA92847V5018
Also trades on
Other OTC · VHIBF (USD)
Toronto Stock Exchange · VHI.TO (CAD)
Description
Vitalhub Corp., through its subsidiaries, provides innovative technological solutions to health and human service providers internationally, specifically catering to markets in Canada, the United States, the United Kingdom, Australia, and Western Asia. The company's diverse array of offerings comprises electronic healthcare records, case management systems, care coordination platforms, tools for optimizing patient flow and operational insights, and various mobile applications. Incorporated in 2010, Vitalhub is headquartered in Toronto, Canada.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CAD7.28
-0.02 (-0.21%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
387.1K
Beta
0.80
Float Shares
52.40M
Free Float %
82.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.38% | +1.53% | +14.35% | +1.66% | -18.67% | -15.84% | -25.37% | +189.82% | +167.45% | +167.45% | +167.45% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
7.28
DCF (Unlevered)
20.40
+180.4%
DCF (Levered)
37.93
+421.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 6 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
3.78
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
2 / 5
Medium
ROA Score
4 / 5
High
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%+58.9% ★ Q1'26: +47.2% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%+69.8% ★ Q1'26: +79.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%+13.5% Q1'26: +7.1% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%+11.2% ★ Q1'26: +13.1% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%+8.2% ★ Q1'26: +7.2% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+18.4% Q1'26: +12.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×0.11× ★ Q1'26: 0.08× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 10 Rev. Ana. 4 EPS Ana. |
Dec 2027 8 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10.23M
est: 10.22M (+0.1%)
|
13.79M
est: 13.40M (+3.0%)
|
24.66M
est: 24.59M (+0.3%)
|
39.97M
est: 39.51M (+1.2%)
|
52.51M
est: 58.32M (-10.0%)
|
68.59M
est: 67.39M (+1.8%)
|
108.97M
est: 108.03M (+0.9%)
|
130.29M
126.20M – 136.22M
+20.6% YoY
|
141.95M
134.44M – 153.93M
+8.9% YoY
|
154.20M
147.63M – 164.34M
+8.6% YoY
|
| EBITDA |
649.4K
est: 1.14M (-43.1%)
|
148.1K
est: 1.50M (-90.1%)
|
1.12M
est: 2.75M (-59.4%)
|
5.25M
est: 4.41M (+19.0%)
|
10.38M
est: 8.88M (+16.9%)
|
11.90M
est: 10.26M (+16.0%)
|
23.25M
est: 16.44M (+41.4%)
|
19.83M
19.21M – 20.73M
+20.6% YoY
|
21.61M
20.46M – 23.43M
+8.9% YoY
|
23.47M
22.47M – 25.02M
+8.6% YoY
|
| EBIT |
-1.12M
est: 25.7K (-4,474.9%)
|
-2.04M
est: 33.7K (-6,156.8%)
|
-1.56M
est: 61.8K (-2,625.2%)
|
1.38M
est: 99.3K (+1,286.4%)
|
5.40M
est: 3.18M (+70.0%)
|
5.94M
est: 3.67M (+61.8%)
|
12.17M
est: 5.88M (+106.9%)
|
7.09M
6.87M – 7.42M
+20.6% YoY
|
7.73M
7.32M – 8.38M
+8.9% YoY
|
8.40M
8.04M – 8.95M
+8.6% YoY
|
| Net Income |
-625.5K
est: -2.29M (+72.7%)
|
-2.17M
est: -2.93M (+26.0%)
|
-1.95M
est: -1.40M (-39.0%)
|
1.21M
est: 5.18M (-76.5%)
|
4.55M
est: 6.42M (-29.1%)
|
3.00M
est: 4.60M (-34.8%)
|
6.11M
est: 6.11M (+0.0%)
|
16.90M
16.58M – 17.22M
+176.5% YoY
|
21.67M
21.37M – 21.98M
+28.3% YoY
|
21.97M
19.36M – 22.25M
+1.4% YoY
|
| SGA |
3.44M
est: 3.82M (-9.8%)
|
5.25M
est: 5.01M (+4.9%)
|
10.41M
est: 9.19M (+13.3%)
|
13.97M
est: 14.77M (-5.4%)
|
18.80M
est: 21.14M (-11.1%)
|
24.56M
est: 24.43M (+0.5%)
|
35.39M
est: 39.16M (-9.6%)
|
47.23M
45.75M – 49.38M
+20.6% YoY
|
51.46M
48.74M – 55.80M
+8.9% YoY
|
55.90M
53.52M – 59.58M
+8.6% YoY
|
| EPS |
-0.04
est: -0.05 (+13.6%)
|
-0.08
est: -0.06 (-43.7%)
|
-0.05
est: -0.03 (-94.5%)
|
0.03
est: 0.10 (-71.4%)
|
0.10
est: 0.10 (-4.7%)
|
0.06
est: 0.08 (-18.9%)
|
0.10
est: 0.06 (+58.6%)
|
0.28
0.27 – 0.29
+344.4% YoY
|
0.36
0.35 – 0.36
+28.3% YoY
|
0.34
0.32 – 0.37
-5.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 2/5 | 4/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 5/5 | 2/5 | 4/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
9.23M
OE per share TTM
0.15
Owner's Yield
1.83%
Maintenance CapEx ratio
13.81%
Maint CapEx / Avg PPE
3.8%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 10 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares S&P/TSX SmallCap Index ETF XCS.TO | 0.13% | 227.9K | 0.60% |
| 2 | iShares Healthcare Innovation UCITS ETF HEAL.L | 0.03% | 356.9K | 0.40% |
| 3 | State Street SPDR S&P International Small Cap ETF GWX | 0.02% | 191.0K | 0.40% |
| 4 | TD Canadian Equity Index ETF TTP.TO | 0.01% | 445.1K | 0.05% |
| 5 | Avantis International Small Cap Equity ETF AVDS | 0.01% | 17.2K | 0.30% |
| 6 | Dimensional - International Small Cap ETF DFIS | 0.00% | 67.6K | 0.39% |
| 7 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 98.7K | 0.22% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 67.7K | 0.28% |
| 9 | Dimensional International Sustainability Core 1 ETF DFSI | 0.00% | — | 0.24% |
| 10 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | — | 0.18% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
24.3K
Shares Outstanding
63.23M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Daniel Matlow | President, Chief Executive Officer & Director | 738.0K | male |
| Lisa Riley | Executive Vice President of Strategy and Growth | 408.4K | female |
| Brian Leonard Goffenberg | Chief Financial Officer & Executive Vice President | 404.9K | male |
| Mike Sanders | Executive Vice President of UK, Europe & Middle East | 370.6K | male |
| Patrick Mazza | Chief Operating Officer | 352.0K | male |
| Niels Tofting | Executive Vice President & MD of North American Operations | 245.0K | male |
| Robert Lazar | Executive Vice President of Professional Services & Customer Care | 245.0K | male |
| Vijit Coomara | Executive Vice President of Product Development | 218.0K | male |
| Graham Farrell | Investor Relations Officer | — | — |
| Christian Sgro | Head of Investor Relations and Mergers & Acquisition Specialist | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VHI.TO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
